UnitedHealth Group Stock Climbs on Eased Prior Authorization Rules
UnitedHealth Group's stock price has seen an uptick as the company announced it will ease prior authorization rules for certain diagnostic codes tied to treatments and procedures. The changes, set to take effect on October 1, 2026, cover a broad mix of services across specialties such as cardiology, genetic and laboratory testing, durable medical equipment, chiropractic care, and various therapies.
The move is seen as a concrete step towards the company's goal of reducing prior authorization volume by 30% by the end of 2026. This adjustment in policy comes on the heels of UnitedHealth Group's August trading range, where shares consolidated around $380-$390 USD. On September 1, 2026, the stock was trading at approximately $395.74 USD.
The company's adjusted earnings guidance for fiscal year 2026 remains a key fundamental support for investors. UnitedHealth Group is guiding for adjusted earnings per share between $19.50 and $20.00, with an analyst consensus of $19.82 as of late August and early September 2026.